Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Introduction
Breast cancer is the second most prevalent cancer among
women and is one of the leading causes of death in women
worldwide [1]. Despite this, advances in screening and diagnostic procedures mean that most breast cancers can be
diagnosed at an early stage, leading to effective treatments
and improved survival rates [2]. Nonetheless, a diagnosis
of breast cancer is a distressing event that affects physical
and psychological functioning and impacts on lifestyle
and relationships with family and friends [35]. Breast
cancer treatments, including systemic adjuvant therapy,
lead to long-term worsened quality of life in breast cancer
survivors [5]. Furthermore, treatment-related changes to
womens physical appearance may affect self-image, and
other effects of treatment, including fatigue, nausea, and
pain, may decrease opportunities for social interactions
and limit the ability of women with breast cancer to continue their normal lifestyle and social activities [6]. This
in turn curtails their opportunities to maintain supportive
social networks and to receive appropriate emotional and
instrumental support.
Copyright 2014 John Wiley & Sons, Ltd.
Method
Participants
The Australian Longitudinal Study on Womens Health
(ALSWH) is a prospective study of the health and wellbeing of three cohorts of women who were aged 1823 years
(19731978 birth cohort), 4550 years (19461951 birth
cohort), and 7075 years (19211926 birth cohort) when
recruited in 1996. The study sample was selected randomly
from the Medicare Australia database (which covers all
citizens and permanent residents of Australia, including
refugees and immigrants), with intentional oversampling
of women living in rural and remote areas in order to achieve
an adequate sample size in this population. The project uses
mailed questionnaires to collect self-report data on health
and related variables every 3 years. Details of the ALSWH
recruitment and study design have been fully described elsewhere [23], and details of the study can be found at www.
alswh.org.au. Participation is voluntary, and the ALSWH
is approved by the University of Newcastle and University
of Queensland Human Research ethics committees.
Copyright 2014 John Wiley & Sons, Ltd.
1015
Measures
Social support was measured by the 19-item Medical
Outcomes Study Social Support Survey [14], with a stem
question that asks, How often is each of the following
kinds of support available to you if you need it? Each
item was answered on a ve-point scale, ranging from
none of the time to all of the time. Scores were from 1
to 5 with higher scores indicating greater levels of social
support. The original four functional support subscales included (1) emotional/informational support (eight items),
(2) tangible support (four items), (3) affectionate support
(three items), and (4) positive social interaction (three
items), and an additional item [14]. Emotional support is
the expression of positive affect, empathic understanding,
and the encouragement of expressions of feelings (e.g.,
share your most private worries and fears with); informational support is the offering of advice, information, guidance, or feedback that can provide a solution to a problem
(e.g., turn to for suggestions about how to deal with a personal problem); positive social interaction is companionship or the availability of other persons to share leisure
and recreational activities (e.g., have a good time with);
affectionate support is the expression of love and affection
Psycho-Oncology 23: 10141020 (2014)
DOI: 10.1002/pon
J. Leung et al.
1016
Statistical analysis
Statistical analyses were conducted using SPSS 19 (IBM
Corp, Armonk, NY, USA). The womens social support
was compared over time, from the survey before diagnosis
of breast cancer (pre-diagnosis) to the survey at which
breast cancer was diagnosed (baseline) and at 3 years follow-up. Repeated-measures analyses of variance
(ANOVAs) were conducted to compare levels of social support over time. Within-subject contrasts were conducted to
compare pre-diagnosis social support with baseline social
support and baseline social support with social support
reported at follow-up. Similarly, repeated-measures
ANOVAs were conducted to compare HRQOL over time.
One-way between-subject ANOVAs were conducted to
compare social support and HRQOL by sociodemographics
(marital status, education, country of birth, and area of
residence) at baseline. The bivariate associations between
baseline social support and follow-up HRQOL were estimated using Pearsons correlation. Partial correlation was
used to estimate the association between social support
Copyright 2014 John Wiley & Sons, Ltd.
Results
Social support and quality of life over time
Women newly diagnosed with breast cancer had moderately high levels of EMI, AFF, and TAN social support
overall, indicated by a mean of 3.974.16 out of a vepoint scale at baseline (Table 1). Repeated-measures
ANOVA results showed that there was no change in social
support pre-diagnosis, at baseline, and after breast cancer
diagnosis.
Compared with pre-diagnosis HRQOL, women newly
diagnosed with breast cancer had signicantly worse quality
of life on the subscales of bodily pain, general health,
physical functioning, role physical, and vitality. However,
compared with when they were newly diagnosed, at follow-up, the women had increased scores in some domains
of HRQOL. Specically, signicant improvements were
observed in their general health, role physical, role emotional, social functioning, and vitality (Table 1).
1017
Table 1. Social support and health-related quality of life at pre-diagnosis, at baseline diagnosis, and at 3-year follow-up after breast cancer
diagnosis
Before diagnosis
M
[95% CI]
Baseline
(1)
M
3.97
4.16
4.10
*
***
**
**
65.12
63.70
77.80
65.18
72.60
73.80
77.04
55.86
Follow-up
M
[95% CI]
[3.79, 4.16]
[3.98, 4.34]
[3.90, 4.29]
[62.38,
[61.21,
[75.49,
[60.61,
[70.49,
[69.63,
[74.15,
[53.30,
4.00
4.16
4.01
67.85]
66.18]
80.11]
69.74]
74.70]
77.96]
79.93]
58.41]
67.24
67.22
78.48
72.73
74.05
79.99
82.14
58.55
[95% CI]
Repeated-measures ANOVA
[3.82, 4.18]
[3.99, 4.32]
[3.81, 4.22]
[64.61,
[64.70,
[76.15,
[68.61,
[72.07,
[76.20,
[79.60,
[56.14,
69.88]
69.74]
80.82]
76.84]
76.03]
83.78]
84.68]
60.96]
0.06
0.30
0.66
<0.01
<0.01
0.01
(2)
**
**
**
**
*
2.73
15.84
5.86
7.59
1.37
4.07
6.07
3.44
0.01
0.05
0.02
0.02
<0.01
0.01
0.02
0.01
***
**
**
*
**
*
Repeated within-subject contrasts were (1) before diagnosis versus baseline and (2) baseline versus follow-up.
CI, condence interval; ANOVA, analysis of variance; EMI, emotional/informational support; AFF, affectionate/positive social interaction support; TAN, tangible support.
*p < 0.05, **p < 0.01, ***p < 0.001.
Table 2. Social support at baseline and health-related quality of life at follow-up by marital status at baseline
Single/divorced/widowed
M
Social support (N = 412)
EMI
3.51
AFF
3.43
TAN
3.25
Health-related quality of life (N = 358)
Bodily pain
62.27
General health
61.11
Physical functioning
70.38
Role physical
72.57
Mental health
69.33
Role emotional
62.33
Social functioning
75.17
Vitality
52.13
[95% CI]
[3.28, 3.73]
[3.20, 3.65]
[3.01, 3.49]
[56.10,
[55.55,
[65.94,
[67.19,
[60.00,
[52.49,
[68.87,
[46.57,
68.44]
66.66]
74.82]
77.96]
78.66]
72.18]
81.47]
57.70]
Married/cohabiting
M
[95% CI]
4.06
4.28
4.16
68.06
69.01
74.76
79.91
82.73
74.73
83.42
60.00
[3.96, 4.16]
[4.18, 4.38]
[4.05, 4.26]
[65.22,
[66.36,
[72.62,
[77.41,
[78.80,
[70.32,
[80.72,
[57.44,
70.91]
71.66]
76.90]
82.40]
86.66]
79.14]
86.13]
62.56]
One-way ANOVA
F
22.43
61.20
58.56
3.24
7.13
3.37
6.75
8.70
6.10
7.01
7.37
Eta squared
***
***
***
**
*
**
*
**
**
0.05
0.13
0.13
0.01
0.02
0.01
0.02
0.02
0.02
0.02
0.02
CI, condence interval; ANOVA, analysis of variance; EMI, emotional/informational support; AFF, affectionate/positive social interaction support; TAN, tangible support.
*p < 0.05, **p < 0.01, ***p < 0.001.
Discussion
Findings from this study indicate that, over time, a diagnosis of breast cancer impacted negatively on HRQOL, but
not on perceived social support, which remained stable.
Those aspects of HRQOL, which were susceptible to
treatment effects (bodily pain, general health, physical
functioning, and vitality), were most likely to be impaired
at time of diagnosis. The correlational results suggested
that emotional/informational support and affectionate
support/positive social interaction, rather than tangible
Psycho-Oncology 23: 10141020 (2014)
DOI: 10.1002/pon
J. Leung et al.
1018
AFF
0.85**
TAN
0.72**
Follow-up health-related quality of life
Bodily pain
0.27**
General health
0.24**
Physical functioning
0.20**
Role physical
0.22**
Mental health
0.27**
Role emotional
0.18**
Social functioning
0.22**
Vitality
0.25**
AFF
TAN
0.71**
0.25**
0.23**
0.19**
0.23**
0.29**
0.24**
0.28**
0.25**
0.18**
0.18**
0.13*
0.18**
0.21**
0.19**
0.18**
0.19**
Figure 1. Structural equation model of social support at baseline predicting health-related quality of life at 3-year follow-up. Standardized
estimates for signicant paths at p < 0.001 are presented. EMI, emotional/informational support; AFF, affectionate/positive social interaction
support; TAN, tangible support
Copyright 2014 John Wiley & Sons, Ltd.
References
1. World Health Organization. World cancer
report 2008. Cedex, International Agency for
Research on Cancer, 2008.
2. American Cancer Society. Breast Cancer
Facts & Figs. 20112012. American Cancer
Society: Atlanta, Georgia, 2012.
3. Bloom JR, Stewart SL, Oakley-Girvan I,
Banks PJ, Shema S. Quality of life of younger
breast cancer survivors: persistence of problems
and sense of well-being. Psycho-Oncology
2012;21:655665.
4. Wade TD, Lee C. The impact of breast cancer
on the lives of middle-aged women: results
from the Australian longitudinal study of
womens health. Health Psychol 2005;24:
246251.
5. Ganz PA, Desmond KA, Leedham B,
Rowland JH, Meyerowitz BE, Belin TR.
6.
7.
8.
9.
1019
Acknowledgements
The research on which this paper is based was conducted as part of
the ALSWH by investigators at the University of Newcastle and the
University of Queensland. The study was approved by the University of Newcastle and University of Queensland Human Research
ethics committees. We are grateful to the Australian Government
Department of Health and Ageing for funding and to the women
who provided the survey data. The funding source had no role in
the design, conduct, and reporting of the study.
Conict of interest
The authors have declared no conicts of interest.
10.
11.
12.
13.
J. Leung et al.
1020
20.
21.
22.
23.
24.
Copyright of Psycho-Oncology is the property of John Wiley & Sons, Inc. and its content
may not be copied or emailed to multiple sites or posted to a listserv without the copyright
holder's express written permission. However, users may print, download, or email articles for
individual use.